Remdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of care given to COVID-19 patients, according to a new study.
from Hindustan Times - topnews https://ift.tt/3d5sXFf
via IFTTT
No comments:
Post a Comment